98-97-5 | 2-Pyrazinecarboxylic acid

Packsize	Purity	Availability	Price	Discounted Price
250mg	98%	in stock	$6.00	$4.00
10g	98%	in stock	$11.00	$8.00
25g	98%	in stock	$14.00	$10.00
100g	97%	in stock	$31.00	$22.00
500g	98%	in stock	$52.00	$36.00

Description

• Catalog Number: AB44220
• Chemical Name: 2-Pyrazinecarboxylic acid
• CAS Number: 98-97-5
• Molecular Formula: C5H4N2O2
• Molecular Weight: 124.0975
• MDL Number: MFCD00006130
• SMILES: OC(=O)c1cnccn1

Computed Properties

• Complexity: 116
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 9
• Hydrogen Bond Acceptor Count: 4
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 1
• XLogP3: 0.1

Literature

• Salicylanilide pyrazinoates inhibit in vitro multidrug-resistant Mycobacterium tuberculosis strains, atypical mycobacteria and isocitrate lyase.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20140312

• A new approach for pyrazinamide susceptibility testing in Mycobacterium tuberculosis.

  Microbial drug resistance (Larchmont, N.Y.) 20120801

• Ubiquitin-proteasome system inhibitors and AMPK regulation in hepatic cold ischaemia and reperfusion injury: possible mechanisms.

  Clinical science (London, England : 1979) 20120701

• In vitro antibacterial and antifungal activity of salicylanilide pyrazine-2-carboxylates.

  Medicinal chemistry (Shariqah (United Arab Emirates)) 20120701

• Role of metal ions on the activity of Mycobacterium tuberculosis pyrazinamidase.

  The American journal of tropical medicine and hygiene 20120701

• Poly[μ(2)-aqua-μ(2)-(pyrazine-2-carboxyl-ato)-lithium].

  Acta crystallographica. Section E, Structure reports online 20120701

• The chemotherapy of tuberculosis: past, present and future.

  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20120601

• catena-Poly[[[diaqua-nickel(II)]-μ-pyrazine-2-carboxyl-ato-silver(I)-μ-pyrazine-2-carboxyl-ato] nitrate dihydrate].

  Acta crystallographica. Section E, Structure reports online 20120501

• Disorder in the anionic part of catena-poly[[(pyrazine-2-carboxyl-ato)copper(II)]-μ-pyrazine-2-carboxyl-ato].

  Acta crystallographica. Section E, Structure reports online 20120401

• Investigation of in situ oxalate formation from 2,3-pyrazinedicarboxylate under hydrothermal conditions using nuclear magnetic resonance spectroscopy.

  Inorganic chemistry 20120319

• Structural motifs in phenylbismuth heterocyclic carboxylates--secondary interactions leading to oligomers.

  Dalton transactions (Cambridge, England : 2003) 20120121

• Pyrazinoic acid efflux rate in Mycobacterium tuberculosis is a better proxy of pyrazinamide resistance.

  Tuberculosis (Edinburgh, Scotland) 20120101

• Electrochemical and spectroscopic investigations of isoniazide and its analogs with ds.DNA at physiological pH: evaluation of biological activities.

  European journal of medicinal chemistry 20120101

• Patterns of pncA mutations in drug-resistant Mycobacterium tuberculosis isolated from patients in South Korea.

  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20120101

• Two-drug antimicrobial chemotherapy: a mathematical model and experiments with Mycobacterium marinum.

  PLoS pathogens 20120101

• Synthesis and characterization of organic impurities in bortezomib anhydride produced by a convergent technology.

  Scientia pharmaceutica 20120101

• MSMEG_2731, an uncharacterized nucleic acid binding protein from Mycobacterium smegmatis, physically interacts with RPS1.

  PloS one 20120101

• Nanoparticle delivery of anti-tuberculosis chemotherapy as a potential mediator against drug-resistant tuberculosis.

  The Yale journal of biology and medicine 20111201

• catena-Poly[[(6-carb-oxy-pyrazine-2-carboxyl-ato)lithium]-μ-aqua].

  Acta crystallographica. Section E, Structure reports online 20111201

• Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis.

  Science (New York, N.Y.) 20110916

• Microbiology. Pyrazinamide--old TB drug finds new target.

  Science (New York, N.Y.) 20110916

• Cytotoxic and antimicrobial activities of Cu(II), Co(II), Pt(II) and Zn(II) Complexes with N,O-chelating heterocyclic carboxylates.

  Archiv der Pharmazie 20110901

• Tris(3-amino-pyrazine-2-carboxyl-ato-κN,O)diaqua-erbium(III) tetra-hydrate.

  Acta crystallographica. Section E, Structure reports online 20110901

• Poly[[(μ-3-amino-pyrazine-2-carboxyl-ato-κN,O:O')diaqua-(μ-oxalato-κO,O:O,O)lanthanum(III)] monohydrate].

  Acta crystallographica. Section E, Structure reports online 20110901

• 8-Hy-droxy-2-methyl-quinolinium tetra-chlorido(pyrazine-2-carboxyl-ato-κN,O)stannate(IV) methanol monosolvate.

  Acta crystallographica. Section E, Structure reports online 20110901

• catena-Poly[[[bis-(3-amino-pyrazine-2-carboxyl-ato)triaqua-praseodymium(III)]-μ-3-amino-pyrazine-2-carboxyl-ato-[(3-amino-pyrazine-2-carboxyl-ato)diaqua-formatopraseodymium(III)]-μ-3-amino-pyrazine-2-carboxyl-ato] hexa-hydrate].

  Acta crystallographica. Section E, Structure reports online 20110901

• Pyrazinamide, but not pyrazinoic acid, is a competitive inhibitor of NADPH binding to Mycobacterium tuberculosis fatty acid synthase I.

  Bioorganic & medicinal chemistry letters 20110815

• catena-Poly[[(aqualithium)-μ-3-carboxypyrazine-2-carboxylato-κO,N:O,N] monohydrate].

  Acta crystallographica. Section E, Structure reports online 20110801

• Poly[[diaquadi-μ(2)-cyanido-bis-(μ(2)-pyrazine-2-carboxyl-ato)dicopper(I)copper(II)] dihydrate].

  Acta crystallographica. Section E, Structure reports online 20110701

• Identification and functional characterization of uric acid transporter Urat1 (Slc22a12) in rats.

  Biochimica et biophysica acta 20110601

• Triethyl-ammonium tetra-chlorido(pyrazine-2-carboxyl-ato-κN,O)stannate(IV).

  Acta crystallographica. Section E, Structure reports online 20110601

• New three-dimensional metal-organic framework with heterometallic [Fe-Ag] building units: synthesis, crystal structure, and functional studies.

  Inorganic chemistry 20110404

• 3-Meth-oxy-carbonyl-1-methyl-pyrazinium tetra-chlorido(pyrazine-2-carboxyl-ato-κN,O)stannate(IV).

  Acta crystallographica. Section E, Structure reports online 20110201

• Poly[[hepta-μ(2)-aqua-bis-(μ(2)-pyrazine-2-carboxyl-ato)dibarium] bis-(pyrazine-2-carboxyl-ate)].

  Acta crystallographica. Section E, Structure reports online 20110201

• Effects of low incubation temperatures on the bactericidal activity of anti-tuberculosis drugs.

  The Journal of antimicrobial chemotherapy 20110101

• Antimicrobial Susceptibility Testing of Mycobacterium bovis Isolates from Michigan White-Tailed Deer during the 2009 Hunting Season.

  Veterinary medicine international 20110101

• Crystal structure of the pyrazinamidase of Mycobacterium tuberculosis: insights into natural and acquired resistance to pyrazinamide.

  PloS one 20110101

• Poly[di-μ-aqua-μ(4)-(pyrazine-2,5-dicarboxyl-ato)-dilithium(I)].

  Acta crystallographica. Section E, Structure reports online 20110101

• Structure-Activity relationship in mutated pyrazinamidases from Mycobacterium tuberculosis.

  Bioinformation 20110101

• Characteristics of pncA mutations in multidrug-resistant tuberculosis in Taiwan.

  BMC infectious diseases 20110101

• Antimycobacterial evaluation of pyrazinoic acid reversible derivatives.

  Current pharmaceutical design 20110101

• Rapid colorimetric testing for pyrazinamide susceptibility of M. tuberculosis by a PCR-based in-vitro synthesized pyrazinamidase method.

  PloS one 20110101

• Yersinia enterocolitica and Yersinia pseudotuberculosis Detection in Foods.

  Journal of pathogens 20110101

• Synthesis, structure and magnetic properties of two new azido-Co(II) coordination architectures: from ferromagnetic coupling to single-chain-magnets.

  Dalton transactions (Cambridge, England : 2003) 20101214

• Kinetics and inhibition of nicotinamidase from Mycobacterium tuberculosis.

  Biochemistry 20101109

• Reductive degradation of pyrazine-2-carboxylate by a newly isolated Stenotrophomonas sp. HCU1.

  Biodegradation 20100901

• Monoclinic modification of aquadi-n-butyl-bis-(pyrazine-2-carboxyl-ato-κN,O)tin(IV).

  Acta crystallographica. Section E, Structure reports online 20100901

• A series of transition metal-azido extended complexes with various anionic and neutral co-ligands: synthesis, structure and their distinct magnetic behavior.

  Dalton transactions (Cambridge, England : 2003) 20100828

• Synthesis and anti-mycobacterial evaluation of some pyrazine-2-carboxylic acid hydrazide derivatives.

  European journal of medicinal chemistry 20100801

• catena-Poly[[[tetra-aqua-erbium(III)]-μ-oxalato-κO,O:O,O] [bromidobis(pyrazine-2-carboxyl-ato-κN,O)cuprate(II)] tetra-hydrate].

  Acta crystallographica. Section E, Structure reports online 20100801

• Xanthine oxidase inhibition by allopurinol increases in vitro pyrazinamide-induced hepatotoxicity in HepG2 cells.

  Drug and chemical toxicology 20100701

• The near future: improving the activity of rifamycins and pyrazinamide.

  Tuberculosis (Edinburgh, Scotland) 20100501

• Poly[aqua-(μ-pyrazine-2-carboxyl-ato-κN,O:O)(μ-pyrazine-2-carboxyl-ato-κN,O:O')lead(II)].

  Acta crystallographica. Section E, Structure reports online 20100501

• Photoluminescent lanthanide-organic bilayer networks with 2,3-pyrazinedicarboxylate and oxalate.

  Inorganic chemistry 20100405

• Peruvian and globally reported amino acid substitutions on the Mycobacterium tuberculosis pyrazinamidase suggest a conserved pattern of mutations associated to pyrazinamide resistance.

  Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 20100301

• N'-[1-(4-Amino-phen-yl)ethyl]pyrazine-2-carbohydrazide.

  Acta crystallographica. Section E, Structure reports online 20100301

• QSAR modeling of a set of pyrazinoate esters as antituberculosis prodrugs.

  Archiv der Pharmazie 20100201

• Renal secretion of uric acid by organic anion transporter 2 (OAT2/SLC22A7) in human.

  Biological & pharmaceutical bulletin 20100101

• Molecular epidemiological study of pyrazinamide-resistance in clinical isolates of mycobacterium tuberculosis from South India.

  International journal of molecular sciences 20100101

• Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand.

  BMC microbiology 20100101

• Epidemiology of gout.

  Arthritis research & therapy 20100101

• Poly[hexa-aqua-bis(μ(3)-terephthalato)(μ(2)-terephthalato)diytterbium(III)].

  Acta crystallographica. Section E, Structure reports online 20100101

• Poly[bis-(μ(2)-pyrazine-2-carboxyl-ato)-κN,O:O';κN,O:O-cadmium(II)].

  Acta crystallographica. Section E, Structure reports online 20100101

• Ligand-based modification of the structures and optical properties of new silver(I)-rhenate(VII) oxide/organic hybrid solids.

  Inorganic chemistry 20091207

• A polymorph of diaqua-bis(pyrazine-2-carboxyl-ato-κN,O)copper(II).

  Acta crystallographica. Section E, Structure reports online 20091201

• Tetra-ethyl-ammonium tricarbonyl-chlorido-(pyrazine-2-carboxyl-ato-N,O)rhenate(I).

  Acta crystallographica. Section E, Structure reports online 20091101

• Substituted N-Phenylpyrazine-2-carboxamides: synthesis and antimycobacterial evaluation.

  Molecules (Basel, Switzerland) 20091020

• Combined Mössbauer spectral and density functional theory determination of the magnetic easy-axis in two high-spin iron(II) 2-pyrazinecarboxylate complexes.

  Inorganic chemistry 20090907

• Poly[diaqua-(μ(2)-oxalato-κO,O:O,O)(μ(2)-pyrazine-2-carboxyl-ato-κN,O:O,O')neodymium(III)].

  Acta crystallographica. Section E, Structure reports online 20090901

• Interpreting expression data with metabolic flux models: predicting Mycobacterium tuberculosis mycolic acid production.

  PLoS computational biology 20090801

• Poly[[hemi-μ(4)-oxalato-hemi-μ(2)-oxalato-bis-(μ(3)-pyrazine-2-carboxyl-ato)erbium(III)silver(I)] monohydrate].

  Acta crystallographica. Section E, Structure reports online 20090801

• Derivatives of pyrazinecarboxylic acid: 1H, 13C and 15N NMR spectroscopic investigations.

  Magnetic resonance in chemistry : MRC 20090701

• Poly[[hemi-μ(4)-oxalato-hemi-μ(2)-oxalato-bis-(μ(3)-pyrazine-2-carboxyl-ato)neodymium(III)silver(I)] monohydrate].

  Acta crystallographica. Section E, Structure reports online 20090701

• Lipophilic pyrazinoic acid amide and ester prodrugs stability, activation and activity against M. tuberculosis.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20090628

• Poly[di-μ(2)-azido-μ(3)-pyrazine-2-carboxyl-ato-cadmium(II)].

  Acta crystallographica. Section E, Structure reports online 20090501

• Protective effects of coffee-derived compounds on lipopolysaccharide/D-galactosamine induced acute liver injury in rats.

  The Journal of pharmacy and pharmacology 20090401

• The identification of orally bioavailable thrombopoietin agonists.

  Bioorganic & medicinal chemistry letters 20090301

• 3-(3-Amino-phenyl-sulfon-yl)aniline.

  Acta crystallographica. Section E, Structure reports online 20090201

• Genome-wide analysis of the PreA/PreB (QseB/QseC) regulon of Salmonella enterica serovar Typhimurium.

  BMC microbiology 20090101

• Mutations found in the pncA gene of Mycobacterium tuberculosis in clinical pyrazinamide-resistant isolates from a local region of China.

  The Journal of international medical research 20090101

• What lies behind serum urate concentration? Insights from genetic and genomic studies.

  Genome medicine 20090101

• Poly[diaqua-μ-oxalato-μ-pyrazine-2-carbox-yl-ato-lanthanum(III)].

  Acta crystallographica. Section E, Structure reports online 20090101

• Metal and mixed-metal coordination polymers synthesized with pyrazine-2-carboxylate.

  Dalton transactions (Cambridge, England : 2003) 20081121

• Vibrational spectroscopic studies and ab initio calculations of a substituted amide of pyrazine-2-carboxylic acid--C12H10ClN3O.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20081115

• Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans.

  The Journal of biological chemistry 20081003

• Poly[diaqua(μ(2)-oxalato-κO,O:O,O)(μ(2)-pyrazine-2-carboxyl-ato-κN,O:O')cerium(III)].

  Acta crystallographica. Section E, Structure reports online 20081001

• Synthesis and structures of a new series of silver-vanadate hybrid solids and their optical and photocatalytic properties.

  Inorganic chemistry 20080915

• 4-Carboxy-pyridazin-1-ium chloride.

  Acta crystallographica. Section E, Structure reports online 20080801

• Identification of a new urate and high affinity nicotinate transporter, hOAT10 (SLC22A13).

  The Journal of biological chemistry 20080613

• Synthesis and antimycobacterial evaluation of substituted pyrazinecarboxamides.

  European journal of medicinal chemistry 20080501

• Mechanistic implications of the active species involved in the oxidation of hydrocarbons by iron complexes of pyrazine-2-carboxylic acid.

  Dalton transactions (Cambridge, England : 2003) 20080421

• Diaqua-bis(pyrazine-2-carboxyl-ato-κN,O)manganese(II) dihydrate.

  Acta crystallographica. Section E, Structure reports online 20080401

• Characterization of Mycobacterium tuberculosis nicotinamidase/pyrazinamidase.

  The FEBS journal 20080201

• Interpretation of the multiple vanadium-oxygen bonds in the central VO(eta2-O2)+ group. Synthesis, structure, supramolecular interactions and DFT studies for complexes with 2,2'-bipyridine, 1,10-phenanthroline, pyrazinato(1-) and pyrazinamide ligands.

  Dalton transactions (Cambridge, England : 2003) 20080107

• Suppression of blood lipid concentrations by volatile Maillard reaction products.

  Nutrition (Burbank, Los Angeles County, Calif.) 20080101

• Silymarin protects liver against toxic effects of anti-tuberculosis drugs in experimental animals.

  Nutrition & metabolism 20080101

• Medical management of genitourinary tuberculosis.

  Indian journal of urology : IJU : journal of the Urological Society of India 20080101

• Dibromidobis(pyrazine-2-carboxylic acid-κN)mercury(II) dihydrate.

  Acta crystallographica. Section E, Structure reports online 20080101

• 2'-(3-Hydroxy-benzyl-idene)pyrazine-2-carbohydrazide monohydrate.

  Acta crystallographica. Section E, Structure reports online 20080101

• Structural determination of hypnosin, a spore germination inhibitor of phytopathogenic Streptomyces sp. causing root tumor in melon (Cucumis sp.).

  Journal of agricultural and food chemistry 20071226

• Substituted N-phenylpyrazine-2-carboxamides, their synthesis and evaluation as herbicides and abiotic elicitors.

  Molecules (Basel, Switzerland) 20071220

• Effect of silibinin on the pharmacokinetics of pyrazinamide and pyrazinoic acid in rats.

  Drug metabolism and disposition: the biological fate of chemicals 20070901

• Agonist lead identification for the high affinity niacin receptor GPR109a.

  Bioorganic & medicinal chemistry letters 20070901

• Oxidation of 2-propanol and cyclohexane by the reagent 'hydrogen peroxide-vanadate anion-pyrazine-2-carboxylic acid': kinetics and mechanism.

  The journal of physical chemistry. A 20070816

• Discovery of pyrazine carboxamide CB1 antagonists: the introduction of a hydroxyl group improves the pharmaceutical properties and in vivo efficacy of the series.

  Bioorganic & medicinal chemistry letters 20070715

• Inhibition of isolated Mycobacterium tuberculosis fatty acid synthase I by pyrazinamide analogs.

  Antimicrobial agents and chemotherapy 20070701

• Pyrazinoic acid and its n-propyl ester inhibit fatty acid synthase type I in replicating tubercle bacilli.

  Antimicrobial agents and chemotherapy 20070201

• Human renal organic anion transporter 4 operates as an asymmetric urate transporter.

  Journal of the American Society of Nephrology : JASN 20070201

• Magnetic properties and molecular structures of binuclear (2-pyrazinecarboxylate)-bridged complexes containing Re(IV) and M(II) (M = Co, Ni).

  Dalton transactions (Cambridge, England : 2003) 20070121

• Concentration-dependent mode of interaction of angiotensin II receptor blockers with uric acid transporter.

  The Journal of pharmacology and experimental therapeutics 20070101

• [Ln2(C2O4)2(pyzc)2(H2O)2]n[Ln = Pr (1), Er (2)]: novel two-dimensional lanthanide coordination polymers with 2-pyrazinecarboxylate and oxalate.

  Inorganic chemistry 20061225

• Effects of weak acids, UV and proton motive force inhibitors on pyrazinamide activity against Mycobacterium tuberculosis in vitro.

  The Journal of antimicrobial chemotherapy 20061101

• pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates from the southeast region of Brazil.

  The Journal of antimicrobial chemotherapy 20061101

• Polar symmetry and intercalation of new multilayered hybrid molybdates: [M2(pzc)2(H2O)x][Mo5O16] (M = Co, Ni).

  Inorganic chemistry 20060612

• Microsphere-based protease assays and screening application for lethal factor and factor Xa.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

• Renal urate transport.

  Rheumatic diseases clinics of North America 20060501

• Versatility in the binding of 2-pyrazinecarboxylate with iron. Synthesis, structure and magnetic properties of iron(II) and iron(III) complexes.

  Dalton transactions (Cambridge, England : 2003) 20060407

• Substituted pyrazinecarboxamides: synthesis and biological evaluation.

  Molecules (Basel, Switzerland) 20060329

• Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome.

  Structure (London, England : 1993) 20060301

• The paradox of pyrazinamide: an update on the molecular mechanisms of pyrazinamide resistance in Mycobacteria.

  The Journal of communicable diseases 20060301

• Acid-base characterization of 5-hydroxypyrazine-2-carboxylic acid and the role of ionic equilibria in the optimization of some process conditions for its biocatalytic production.

  Analytical and bioanalytical chemistry 20051001

• A density functional theory study of the mechanism of free radical generation in the system vanadate/PCA/H2O2.

  The journal of physical chemistry. B 20050929

• Structural origin of chirality and properties of a remarkable helically pillared solid.

  Inorganic chemistry 20050919

• Phenolsulfonphthalein transport by potential-sensitive urate transport system.

  European journal of pharmacology 20050822

• Hydrothermal syntheses and structures of two mixed-valence copper(I,II) 2-pyrazinecarboxylate coordination polymers.

  Inorganic chemistry 20050530

• Sodium-coupled and electrogenic transport of B-complex vitamin nicotinic acid by slc5a8, a member of the Na/glucose co-transporter gene family.

  The Biochemical journal 20050515

• Synthesis and characterization of ReO4-containing microporous and open framework structures.

  Inorganic chemistry 20040906

• Anaerobic incubation conditions enhance pyrazinamide activity against Mycobacterium tuberculosis.

  Journal of medical microbiology 20040801

• Self-assembly of diorganotin(IV) moieties and 2-pyrazinecarboxylic acid: syntheses, characterizations and crystal structures of monomeric, polymeric or trinuclear macrocyclic compounds.

  Dalton transactions (Cambridge, England : 2003) 20040621

• Iron enhances the antituberculous activity of pyrazinamide.

  The Journal of antimicrobial chemotherapy 20040201

• Function and localization of urate transporter 1 in mouse kidney.

  Journal of the American Society of Nephrology : JASN 20040201

• A mixed matrix of 3-hydroxypicolinic acid and pyrazinecarboxylic acid for matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of oligodeoxynucleotides.

  Rapid communications in mass spectrometry : RCM 20040101

• Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid.

  The Journal of antimicrobial chemotherapy 20031101

• Urate transport via human PAH transporter hOAT1 and its gene structure.

  Kidney international 20030101

• The curious characteristics of pyrazinamide: a review.

  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20030101

• Augmentation of H2 photoproduction in Rhodopseudomonas palustris by N-heterocyclic aromatic compounds.

  Biotechnology letters 20030101

• Synthesis and antimycobacterial activity of pyrazine and quinoxaline derivatives.

  Journal of medicinal chemistry 20021205

• Functional analysis and molecular model of the human urate transporter/channel, hUAT.

  American journal of physiology. Renal physiology 20020701

• Investigation of the effects of concomitant caffeine administration on the metabolic disposition of pyrazinamide in rats.

  Biopharmaceutics & drug disposition 20020701

• Growth-promoting activity of pyrazinoic acid, a putative active compound of antituberculosis drug pyrazinamide, in niacin-deficient rats through the inhibition of ACMSD activity.

  Bioscience, biotechnology, and biochemistry 20020701

• Escherichia coli genes involved in resistance to pyrazinoic acid, the active component of the tuberculosis drug pyrazinamide.

  FEMS microbiology letters 20020604

• Effects of pyrazinamide on fatty acid synthesis by whole mycobacterial cells and purified fatty acid synthase I.

  Journal of bacteriology 20020401

• Recurrence of carboxylic acid-pyridine supramolecular synthon in the crystal structures of some pyrazinecarboxylic acids.

  The Journal of organic chemistry 20020125

• Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide.

  Journal of medical microbiology 20020101

• A new packing variant of catena-poly[[aquachlorocopper(II)]-mu-pyrazine-2-carboxylato-O,N:N'].

  Acta crystallographica. Section C, Crystal structure communications 20011201

• Crystal structure and mechanism of catalysis of a pyrazinamidase from Pyrococcus horikoshii.

  Biochemistry 20011127

• Anion-directed crystallization of coordination polymers: syntheses and characterization of Cu(4)(2-pzc)(4)(H(2)O)(8)(Mo(8)O(26)).2H(2)O and Cu(3)(2-pzc)(4)(H(2)O)(2)(V(10)O(28)H(4)).6.5H(2)O (2-pzc = 2-pyrazinecarboxylate).

  Inorganic chemistry 20010312

• Bioisosteres of 9-carboxymethyl-4-oxo-imidazo[1,2-a]indeno-[1,2-e]pyrazin-2-carboxylic acid derivatives. Progress towards selective, potent in vivo AMPA antagonists with longer durations of action.

  Bioorganic & medicinal chemistry letters 20010122

• pncA mutations in clinical Mycobacterium tuberculosis isolates from Korea.

  BMC infectious diseases 20010101

• The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis.

  Respiratory research 20010101

• Correlation of pncA sequence with pyrazinamide resistance level in BACTEC for 21 mycobacterium tuberculosis clinical isolates.

  Microbial drug resistance (Larchmont, N.Y.) 20000101

• Quantitative structure-activity relationships for the in vitro antimycobacterial activity of pyrazinoic acid esters.

  Journal of medicinal chemistry 19960816

• Pyrazinoic acid esters with broad spectrum in vitro antimycobacterial activity.

  Journal of medicinal chemistry 19950929

• Activity of n-propyl pyrazinoate against pyrazinamide-resistant Mycobacterium tuberculosis: investigations into mechanism of action of and mechanism of resistance to pyrazinamide.

  Antimicrobial agents and chemotherapy 19950601

• Structure-activity relationship of ligands of uracil phosphoribosyltransferase from Toxoplasma gondii.

  Biochemical pharmacology 19940817

• Antimycobacterial activity of a series of pyrazinoic acid esters.

  Journal of medicinal chemistry 19920403

• Pyrazinamide and pyrazinoic acid activity against tubercle bacilli in cultured human macrophages and in the BACTEC system.

  The Journal of infectious diseases 19900701

• Does pyrazinoic acid as an active moiety of pyrazinamide have specific activity against Mycobacterium tuberculosis?

  Antimicrobial agents and chemotherapy 19890801

• Role of rifampicin in arthralgia induced by pyrazinamide.

  Tubercle 19830601

• Pyrazinamide susceptibility and amidase activity of tubercle bacilli.

  The American review of respiratory disease 19670301